Fundraising Fox
Eli Lilly
NYSE: LLYIncorporated in Indiana · 4 known investors
Find your way into Eli Lilly
Sign up to see every warm intro you have to Eli Lilly
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Eli Lilly team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Eli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.
Founders & leadership
Investors · 4
Founder mafia
The Eli Lilly mafia →73 people who came through Eli Lilly went on to found or lead other companies.
Jonathan P. NorthrupVP, Business development & StrategyFounded Beta Cat Pharmaceuticals +2Paul F. TruexManagerFounded Lqttrx +2Dirk ReynSales ManagerFounded Spectricity +1Scott ByrdUS and Global Brand Leader - Cardiovascular and Critical CareFounded Outpost Medicine +1Jacopo LeonardiNew Product Planning ManagerFounded 4D Path +1Kevin JudiceSenior Vice President, Lilly Research Laboratories, and CEO of DICE TherapeuticsFounded DiCE Molecules +1Justin WisemanAssoc. Analytical ChemistFounded Prosolia, Inc. +1Stacy LindborgQuantitative Pharmacology, Board MemberFounded BrainStorm Cell Therapeutics +1Howard BermanMedical AffairsFounded Coya Therapeutics +1Steve CarchediDirector Oncology Product Group- Global Oncology Franchise LeaderFounded Cornerstone Pharmaceuticals +1Martin BablervariousFounded Alumis +1Matt TindallSpecialty Sales Representative, Women's HealthFounded FlightPath +1
Acquisitions · 1
Early investors' stakes continue via these dealsAcanthas
Developer of an oral small molecule targeting a mutation involved in acute myeloid leukemia, sarcomas, and gliomas; acquired by Eli Lilly.
In the news
Frequently asked questions
- What does Eli Lilly do?
- Eli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.
- Who founded Eli Lilly?
- Eli Lilly was founded by Eli Lilly.
- Who are Eli Lilly's investors?
- Eli Lilly's investors include Aditum Bio, Kleiner Perkins, MassChallenge Mexico, Micron Ventures.